Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.99M | 1.85M | 1.90M | 1.41M | 1.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.90M | 2.78M | 2.78M | 2.27M | 2.25M |
| Operating Income | -2.90M | -2.78M | -2.78M | -2.27M | -2.25M |
| Income Before Tax | 4.53M | -3.05M | -2.93M | -3.04M | -2.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.53 | -3.05 | -2.93 | -3.04 | -2.71 |
| Earnings from Discontinued Operations | -144.30K | -328.40K | -328.40K | -328.40K | -328.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.39M | -3.38M | -3.26M | -3.37M | -3.04M |
| EBIT | -2.90M | -2.78M | -2.78M | -2.27M | -2.25M |
| EBITDA | -2.69M | -2.49M | -2.43M | -1.83M | -1.81M |
| EPS Basic | 3.98 | -3.27 | -3.17 | -3.33 | -3.04 |
| Normalized Basic EPS | -1.67 | -1.84 | -1.78 | -1.88 | -1.69 |
| EPS Diluted | 3.98 | -3.27 | -3.17 | -3.33 | -3.04 |
| Normalized Diluted EPS | -1.67 | -1.84 | -1.78 | -1.88 | -1.69 |
| Average Basic Shares Outstanding | 4.27M | 4.19M | 4.11M | 4.02M | 4.00M |
| Average Diluted Shares Outstanding | 4.27M | 4.19M | 4.11M | 4.02M | 4.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |